The funding will help expand access to the company’s robotic microsurgery system in the US and other international markets.
The Symani robotic system is designed for soft tissue open surgery, allowing surgeons to repair tiny structures such as lymphatic vessels and nerves. The robot filters out tremors while translating the surgeon’s hand and wrist motions into robotic movement of its miniaturized instruments.